Jacques Pierre Moreau
Directeur/Bestuurslid bij Mulleris Therapeutics, Inc.
Actieve functies van Jacques Pierre Moreau
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Mulleris Therapeutics, Inc. | Directeur/Bestuurslid | - | - |
Chondiothera, Inc. | Directeur/Bestuurslid | - | - |
Loopbaan van Jacques Pierre Moreau
Eerdere bekende functies van Jacques Pierre Moreau
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Directeur/Bestuurslid | - | 03-02-2014 |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Directeur/Bestuurslid | 24-06-2011 | 03-12-2012 |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
Oprichter | - | - | |
IPSEN | Hoofd Techniek/Wetenschap/O&O | 01-01-1994 | - |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Algemeen Directeur | 01-10-1976 | - |
Oprichter | 01-10-1976 | - | |
President | 01-10-1976 | - | |
DR. REDDY'S LABORATORIES LIMITED | Directeur/Bestuurslid | 18-05-2007 | - |
Independent Dir/Board Member | 24-06-2011 | - |
Opleiding van Jacques Pierre Moreau
University of Orléans | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
India | 2 |
2 |
Operationeel
Director/Board Member | 6 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DR. REDDY'S LABORATORIES LIMITED | Health Technology |
IPSEN | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
Mulleris Therapeutics, Inc. | |
Chondiothera, Inc. | |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Health Technology |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |